Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer’s disease
Abstract This study investigated the relationships among plasma biomarkers, regional brain atrophy, and clinical symptoms in patients with Alzheimer’s disease (AD; n = 177), mild cognitive impairment (MCI; N = 60) and controls (n = 108). The Mini-Mental Status Examination (MMSE), Clinical Dementia R...
Guardado en:
Autores principales: | Jung-Lung Hsu, Wei-Ju Lee, Yi-Chu Liao, Jiing-Feng Lirng, Shuu-Jiun Wang, Jong-Ling Fuh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d99495a9982945c99a4047207fbf8b9d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: A Two-year Follow-up Study
por: Wei-Ju Lee, et al.
Publicado: (2018) -
Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions
por: Millán-Calenti JC, et al.
Publicado: (2016) -
Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI.
por: Jon B Toledo, et al.
Publicado: (2013) -
Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
por: Yuek Ling Chai, et al.
Publicado: (2021) -
Severe agitation in severe early-onset Alzheimer’s disease resolves with ECT
por: Aksay SS, et al.
Publicado: (2014)